loadpatents
name:-0.019737958908081
name:-0.0062949657440186
name:-0.0093839168548584
Engleman; Edgar George Patent Filings

Engleman; Edgar George

Patent Applications and Registrations

Patent applications and USPTO patent grants for Engleman; Edgar George.The latest application filed is for "immunoconjugates targeting her2".

Company Profile
8.6.17
  • Engleman; Edgar George - Atherton CA
  • Engleman; Edgar George - Redwood City CA
  • Engleman; Edgar George - Palo Alto CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Immunoconjugates targeting HER2
Grant 11,400,164 - Ackerman , et al. August 2, 2
2022-08-02
Immunoconjugates Targeting HER2
App 20220226492 - Ackerman; Shelley Erin ;   et al.
2022-07-21
Immunoconjugates Targeting PD-L1
App 20220226491 - Ackerman; Shelley Erin ;   et al.
2022-07-21
Immunoconjugates Targeting CEA
App 20220152215 - Ackerman; Shelley Erin ;   et al.
2022-05-19
Macromolecule-Supported TLR Agonists
App 20220143012 - Ackerman; Shelley Erin ;   et al.
2022-05-12
Immunoconjugates Targeting HER2
App 20220001022 - Ackerman; Shelley Erin ;   et al.
2022-01-06
Antibody adjuvant conjugates
Grant 11,110,178 - Alonso , et al. September 7, 2
2021-09-07
Immunoconjugates Targeting EGFR
App 20210187115 - Alonso; Michael N. ;   et al.
2021-06-24
Immunoconjugates
App 20210154316 - Alonso; Michael N. ;   et al.
2021-05-27
Methods and Compositions for Antibody and Antibody-loaded Dendritic Cell Mediated Therapy
App 20210024649 - Engleman; Edgar George ;   et al.
2021-01-28
Antibody Adjuvant Conjugates
App 20200206357 - Alonso; Michael Nathaniel ;   et al.
2020-07-02
Antibody adjuvant conjugates
Grant 10,675,358 - Alonso , et al.
2020-06-09
Methods For Cancer Treatment
App 20200164195 - Lowsky; Robert ;   et al.
2020-05-28
Methods and Compositions for Dectin-2 Stimulation and Cancer Immunotherapy
App 20200140556 - KENKEL; Justin ;   et al.
2020-05-07
Methods for cancer treatment
Grant 10,549,082 - Lowsky , et al. Fe
2020-02-04
Antibody Adjuvant Conjugates
App 20190076547 - Alonso; Michael Nathaniel ;   et al.
2019-03-14
Methods And Compositions For Dectin-2 Stimulation And Cancer Immunotherapy
App 20190010236 - Kenkel; Justin ;   et al.
2019-01-10
Reversing intestinal inflammation by inhibiting retinoic acid metabolism
Grant 10,039,751 - Penny , et al. August 7, 2
2018-08-07
Reversing Intestinal Inflammation By Inhibiting Retinoic Acid Metabolism
App 20170189384 - Penny; Hweixian Leong ;   et al.
2017-07-06
Reversing intestinal inflammation by inhibiting retinoic acid metabolism
Grant 9,623,013 - Penny , et al. April 18, 2
2017-04-18
Methods and Compositions for Antibody and Antibody-loaded Dendritic Cell Mediated Therapy
App 20160340439 - Engleman; Edgar George ;   et al.
2016-11-24
Reversing Intestinal Inflammation by Inhibiting Retinoic Acid Metabolism
App 20160158206 - Penny; Hweixian Leong ;   et al.
2016-06-09
Methods for Cancer Treatment
App 20160058993 - Lowsky; Robert ;   et al.
2016-03-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed